Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents

about

Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents

Item

http://www.wikidata.org/entity/Q58794595

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Strategies for Continued Succe ...... Between Pharmacological Agents

@en

Strategies for Continued Succe ...... Between Pharmacological Agents

@nl

type

Item

label

Strategies for Continued Succe ...... Between Pharmacological Agents

@en

Strategies for Continued Succe ...... Between Pharmacological Agents

@nl

prefLabel

Strategies for Continued Succe ...... Between Pharmacological Agents

@en

Strategies for Continued Succe ...... Between Pharmacological Agents

@nl

P1476

Strategies for Continued Succe ...... Between Pharmacological Agents

@en

P2093

George Grossberg

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Toriyama

http://www.w3.org/2001/XMLSchema#string

Kengo Ueda

http://www.w3.org/2001/XMLSchema#string

Rafael Blesa

http://www.w3.org/2001/XMLSchema#string

Sean Knox

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for Alzheimer's disease

Rivastigmine for Alzheimer's disease

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

Alzheimer's disease.

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.

Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study.

P304

964-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1567205015666180613112040

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29895249

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6142408

http://www.w3.org/2001/XMLSchema#string